0001209191-16-129048.txt : 20160621
0001209191-16-129048.hdr.sgml : 20160621
20160621163616
ACCESSION NUMBER: 0001209191-16-129048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160617
FILED AS OF DATE: 20160621
DATE AS OF CHANGE: 20160621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Juno Therapeutics, Inc.
CENTRAL INDEX KEY: 0001594864
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463656275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 2066960703
MAIL ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levitsky Hyam
CENTRAL INDEX KEY: 0001375792
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36781
FILM NUMBER: 161724755
MAIL ADDRESS:
STREET 1: C/O ANTIGENICS INC.
STREET 2: 162 FIFTH AVE., SUITE 900
CITY: NEW YORK
STATE: NY
ZIP: 10010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-17
0
0001594864
Juno Therapeutics, Inc.
JUNO
0001375792
Levitsky Hyam
C/O 307 WESTLAKE AVENUE N STE 300
SEATTLE
WA
98109
0
1
0
0
EVP, Research & CSO
Common Stock
2016-06-17
4
S
0
12118
42.7563
D
117000
D
Common Stock
2016-06-17
4
S
0
300
43.20
D
116700
D
This transaction was executed in multiple trades at prices ranging from $42.195 to $43.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2016.
/s/ Zachary Hale, attorney-in-fact
2016-06-21